Active, not recruitingNot applicableNCT01820884

The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Ding Ma
Principal Investigator: Beihua Kong, MD, PhD
Shandong University
Intervention: TH(procedure)
Enrollment: 240 target
Eligibility: 18-50 years · FEMALE
Timeline: 2012 – 2026

Study locations (3)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Qilu Hospital，Shandong University, Jinan, Shandong, China
Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Collaborators

Shandong University · Huazhong University of Science and Technology · Zhejiang University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01820884 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary →

← Back to all trials